A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)
A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)
Active, not recruiting · NCT06433531 · Registry updated 2025-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, generalized pustular psoriasis, psoriasis, skin disorder | Active, not recruiting | Phase 1 | 2025-07-30 | NCT06433531 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 32 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dermatology Hospital of Southern Medical Universitye | Guangzhou | China | 1 |
| Peking University First Hospital | Beijing | China | 1 |
| Second People's Hospital of Chengdu | Chengdu | China | 1 |
| The First Hospital of China Medical University | Shenyang | China | 16 |
| The First Hospital of Hebei Medical University | Shijiazhuang | China | 7 |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou | China | 11 |
| The Second Hospital of Hebei Medical University | Shijiazhuang | China | 30 |